HOPPS, Eugenia
 Distribuzione geografica
Continente #
NA - Nord America 5.412
EU - Europa 2.230
AS - Asia 1.637
SA - Sud America 366
AF - Africa 45
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.696
Nazione #
US - Stati Uniti d'America 5.358
IT - Italia 921
SG - Singapore 656
CN - Cina 479
BR - Brasile 308
FI - Finlandia 282
HK - Hong Kong 190
DE - Germania 162
RU - Federazione Russa 153
UA - Ucraina 152
IE - Irlanda 135
GB - Regno Unito 112
PL - Polonia 87
VN - Vietnam 68
FR - Francia 50
KR - Corea 47
NL - Olanda 44
SE - Svezia 44
BD - Bangladesh 28
IN - India 28
CA - Canada 27
TR - Turchia 27
RO - Romania 21
IQ - Iraq 20
MX - Messico 20
AR - Argentina 17
BE - Belgio 15
CI - Costa d'Avorio 15
IR - Iran 15
EC - Ecuador 12
JP - Giappone 10
ES - Italia 9
UZ - Uzbekistan 9
AT - Austria 8
IL - Israele 8
MA - Marocco 8
SA - Arabia Saudita 8
ID - Indonesia 6
PK - Pakistan 6
UY - Uruguay 6
ZA - Sudafrica 6
AM - Armenia 5
TN - Tunisia 5
BO - Bolivia 4
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
KZ - Kazakistan 4
PE - Perù 4
PY - Paraguay 4
AU - Australia 3
BG - Bulgaria 3
CY - Cipro 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
AL - Albania 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
KE - Kenya 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
EU - Europa 1
GF - Guiana Francese 1
HN - Honduras 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
RE - Reunion 1
SC - Seychelles 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.696
Città #
Fairfield 738
Ashburn 599
Houston 457
Chandler 362
Woodbridge 358
Singapore 352
Wilmington 310
Seattle 304
Cambridge 280
Ann Arbor 202
Hong Kong 186
Palermo 146
Dublin 135
Medford 116
Des Moines 103
Beijing 93
Nanjing 83
Princeton 76
Dallas 72
Jacksonville 72
Zgierz 71
Altamura 69
Santa Clara 64
Boardman 55
Moscow 55
Lawrence 51
San Diego 41
Rome 40
The Dalles 38
Milan 37
Los Angeles 36
Dearborn 35
New York 34
Munich 33
Shenyang 31
Tulsa 28
Seongnam 26
Council Bluffs 22
Ho Chi Minh City 20
Jiaxing 20
São Paulo 19
Buffalo 18
Hebei 18
London 18
Nanchang 18
Tianjin 18
Jinan 17
Phoenix 17
Hanoi 16
Abidjan 15
Brussels 15
Ludwigshafen am Rhein 14
Naples 14
Ningbo 14
Rio de Janeiro 14
Helsinki 13
Redwood City 13
Changsha 12
Guangzhou 12
Kumar 11
Saint Petersburg 11
Belo Horizonte 10
Chicago 10
Columbus 10
Falls Church 10
Orange 10
San Paolo di Civitate 10
Tehran 10
Venice 10
Campinas 9
Florence 9
Hefei 9
Zhengzhou 9
Dhaka 8
Tokyo 8
Bexley 7
Cagliari 7
Catania 7
Hangzhou 7
Izmir 7
Kilburn 7
Paris 7
Toronto 7
Atlanta 6
Chiswick 6
Frankfurt am Main 6
Genova 6
Hofheim am Taunus 6
Istanbul 6
Nuremberg 6
Salvador 6
Shanghai 6
Stockholm 6
Warsaw 6
Washington 6
Amsterdam 5
Auburn Hills 5
Erbil 5
Indiana 5
Manchester 5
Totale 6.452
Nome #
Alterazioni emoreologiche nella sindrome metabolica 427
Clinical conditions responsible for hyperviscosity and skin ulcers complications 384
Lipid Peroxidation, Protein Oxidation, Gelatinases, and Their Inhibitors in a Group of Adults with Obesity 332
Behaviour of the neutrophil to lymphocyte ratio in young subjects with acute myocardial infarction 293
Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment 224
Analysis of the Blood Viscosity Behavior in the Sicilian Study on Juvenile Myocardial Infarction 216
Behavior of the total antioxidant status in a group of subjects with metabolic syndrome. 206
Aspetti emoreologici nella iperviscosità policitemica e sierica 200
Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers. 198
A novel component of the metabolic syndrome : The oxidative stress 193
Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome 187
Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS) 184
Effects of exercise on inflammation markers in type 2 diabetic subjects. 181
Erythrocyte deformability and hemorheological profile in multiple myeloma 177
Clinical disorders responsible for plasma hyperviscosity and skin complications 174
Lipid peroxidation and nitric oxide metabolites in a group of subjects with obstructive sleep apnea syndrome 171
Erythrocyte deformability, plasma lipid peroxidation and plasma protein oxidation in a group of OSAS subjects 162
Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. 158
Protein oxidation in a group of subjects with metabolic syndrome. 153
Hemorheological abnormalities in human arterial hypertension 152
Red blood cell deformability in multiple myeloma 144
Fluidity and cytosolic Ca2+ concentration of circulating polymorphonuclear leukocytes at baseline in some chronic and acute clinical conditions: review of our survey 143
Polymorphonuclear leukocytes and diabetes mellitus. 140
Lipid Peroxidation, Nitric Oxide Metabolites, and Their Ratio in a Group of Subjects with Metabolic Syndrome 137
Nitric oxide metabolites and oxidative stress in mild essential hypertension 134
Pathophysiology of polymorphonuclear leukocyte in arterial hypertension. 131
Analysis of the correlations between oxidative stress, gelatinases and their tissue inhibitors in the human subjects with obstructive sleep apnea syndrome 128
Leucociti polimorfonucleati e diabete mellito 127
Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome. 125
Gelatinases and physical exercise: A systematic review of evidence from human studies 124
Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey 122
Protein oxidation in metabolic syndrome 121
Hemorheological abnormalities in human arterial hypertension 121
Protein oxidation in chronic kidney disease 121
Deformabilità eritrocitaria, metaboliti dell'ossido nitrico e stress ossidativo in un gruppo di soggetti con sindrome delle apnee ostruttive nel sonno 120
Portopulmonary hypertension 117
Plasma Viscosity and NLR in Young Subjects with Myocardial Infarction: Evaluation at the Initial Stage and at 3 and 12 Months 117
Protein oxidation in mild essential hypertension 112
Oxidative status in nondiabetic middle-aged subjects with metabolic syndrome: preliminary data. 111
Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects 110
PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM 110
Exercise in obesity management 108
Oxidative status in metabolic syndrome 107
Short-Term Prognosis of Juvenile Myocardial Infarction: Role of Plasma Viscosity 106
Iperviscosita' sclerocitemica da alterazioni congenite della membrana eritrocitaria 105
Deformabilità eritrocitaria e metaboliti dell'ossido nitrico in un gruppo di soggetti con sindrome delle apnee ostruttive nel sonno 105
Gelatinases and their tissue inhibitors in metabolic syndrome 103
Matrix metalloproteinases in metabolic syndrome. 102
Study of the Correlations among Some Parameters of the Oxidative Status, Gelatinases, and Their Inhibitors in a Group of Subjects with Metabolic Syndrome 101
Eventi vascolari correlati ad alcune condizioni di iperviscosità sclerocitemica 100
Nitric oxide metabolites (nitrite and nitrate) in several clinical condition 99
Molecole di adesione e malattia diabetica 96
Alterazioni funzionali leucocitarie nella malattia ipertensiva 95
Emoreologia ed ipertensione 95
Metabolic syndrome: from insulin resistance to adipose tissue dysfunction. 94
Lipid peroxidation and protein oxidation are related to the severity of OSAS 94
La microangiopatia diabetica 92
Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome 91
Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome 91
Comportamento delle gelatinasi e dei loro inibitori tissutali nella sindrome metabolica 89
Deformabilità eritrocitaria nella policitemia vera 88
Interrelazioni tra disfunzione endoteliale e stress ossidativo; valutazione della perossidazione lipidica in particolari quadri clinici 88
Profilo emoreologico nell'infarto miocardico giovanile: nuove acquisizioni 87
Metalloproteinasi, stress ossidativo e sindrome metabolica 86
Studio dei parametri dello stress ossidativo e della reologia eritrocitaria in soggetti affetti da sindrome delle apnee ostruttive nel sonno (OSAS) 84
Polymorphonuclear leukocyte rheology, cytosolic Ca2+ content, beta2-integrin expression and oxidative stress in hypertension. 83
Protein carbonyl groups in trained subjects before and after a cardiopulmonary test 82
Lipid peroxidation and protein oxidation are related to the severity of OSAS 79
Membrane fluidity and cytosolic Ca2+ concentration of the circulating polymorphonuclear leukocytes in diabetes mellitus 78
Studio delle interrelazioni tra stress ossidativo, gelatinasi e loro inibitori in soggetti con sindrome delle apnee ostruttive nel sonno 69
The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey 67
Haemorheological profile in congenital afibrinogenemia and in congenital dysfibrinogenemia: A clinical case report 65
PMN membrane fluidity, cytosolic Ca2+ content and beta2-integrin pattern in vascular atherosclerotic disease 63
Ulcere venose: rilievi riguardanti sia aspetti reologici e funzionali dei polimorfonucleati che le concentrazioni plasmatiche delle gelatinasi e dei loro inibitori 62
Totale 9.941
Categoria #
all - tutte 37.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 36 106 87 111 124 62 101
2021/2022830 30 156 36 50 22 36 29 61 102 90 70 148
2022/20231.097 112 207 19 113 126 165 81 69 126 3 47 29
2023/2024506 27 85 46 46 49 79 47 19 6 22 29 51
2024/20251.511 45 143 170 110 63 65 102 113 91 122 206 281
2025/20261.309 261 103 224 241 314 166 0 0 0 0 0 0
Totale 9.941